Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Point32Health | Somatostatin Analogs for Non-oncology Indications | New policy |
| Aug 2, 2026 | Point32Health | Somatostatin Analogs for Non-Oncology Indications | New policy |
| Aug 2, 2026 | Point32Health | Somatostatin Analogs | New policy |
| Aug 2, 2026 | Point32Health | Skysona (elivaldogene autotemcel) | New policy |
| Aug 2, 2026 | Point32Health | Short-Acting Colony Stimulating Factors | New policy |
| Aug 2, 2026 | Point32Health | Scenesse (afamelanotide) | New policy |
| Aug 2, 2026 | Point32Health | Scenesse (afamelanotide) | New policy |
| Aug 2, 2026 | Point32Health | Saphnelo (anifrolumab-fnia) | New policy |
| Aug 2, 2026 | Point32Health | Saphnelo (anifrolumab-fnia) | New policy |
| Aug 2, 2026 | Point32Health | Rytelo (imetelstat) | New policy |
| Aug 2, 2026 | Point32Health | Rytelo (imetelstat) | New policy |
| Aug 2, 2026 | Point32Health | Rystiggo (rozanolixizumab-noll) | New policy |
| Aug 2, 2026 | Point32Health | Rystiggo (rozanolixizumab-noli) | New policy |
| Aug 2, 2026 | Point32Health | Ryoncil (remestemcel-L) | New policy |
| Aug 2, 2026 | Point32Health | Rykindo (risperidone) | New policy |
| Aug 2, 2026 | Point32Health | Rituximab products for non-oncology indications | New policy |
| Aug 2, 2026 | Point32Health | Rituximab Products for Oncology Indications | New policy |
| Aug 2, 2026 | Point32Health | Rituximab Products for Oncology Indications | New policy |
| Aug 2, 2026 | Point32Health | Rituximab Products for Non-oncology Indications | New policy |
| Aug 2, 2026 | Point32Health | Rituximab Products | New policy |
| Aug 2, 2026 | Point32Health | Respiratory Interleukins Skilled administration | New policy |
| Aug 2, 2026 | Point32Health | Respiratory Interleukins | New policy |
| Aug 2, 2026 | Point32Health | Respiratory Interleukins | New policy |
| Aug 2, 2026 | Point32Health | Respiratory Interleukins | New policy |
| Aug 2, 2026 | Point32Health | Repository Corticotropin (skilled administration) | New policy |
| Aug 2, 2026 | Point32Health | Reblozyl (luspatercept-aamt) | New policy |
| Aug 2, 2026 | Point32Health | Reblozyl (luspatercept-aamt) | New policy |
| Aug 2, 2026 | Point32Health | Radicava (edaravone) | New policy |
| Aug 2, 2026 | Point32Health | Radicava (edaravone) | New policy |
| Aug 2, 2026 | Point32Health | Qfitlia (fitusiran) | New policy |
| Aug 2, 2026 | Point32Health | Qfitlia (fitusiran) | New policy |
| Aug 2, 2026 | Point32Health | Qalsody (tofersen) | New policy |
| Aug 2, 2026 | Point32Health | Qalsody (tofersen) | New policy |
| Aug 2, 2026 | Point32Health | Pulmonary Hypertension Medications | New policy |
| Aug 2, 2026 | Point32Health | Pulmonary Hypertension Medications | New policy |
| Aug 2, 2026 | Point32Health | Provenge (sipuleucel-T) | New policy |
| Aug 2, 2026 | Point32Health | Prolia (denosumab) and Biosimilars | New policy |
| Aug 2, 2026 | Point32Health | Prolia (denosumab) and Biosimilar | New policy |
| Aug 2, 2026 | Point32Health | Proleukin (aldesleukin) | New policy |
| Aug 2, 2026 | Point32Health | Prevymis (letermovir) | New policy |
| Aug 2, 2026 | Point32Health | Pluvicto (lutetium Lu 177 vipivotide tetraxetan) | New policy |
| Aug 2, 2026 | Point32Health | Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) | New policy |
| Aug 2, 2026 | Point32Health | Papzimeos (zopapogene imadenovecdrba) | New policy |
| Aug 2, 2026 | Point32Health | Papzimeos (zopapogene imadenovec-drba) | New policy |
| Aug 2, 2026 | Point32Health | Oxlumo (lumasiran) | New policy |
| Aug 2, 2026 | Point32Health | Oxlumo (lumasiran) | New policy |
| Aug 2, 2026 | Point32Health | Opdualag (nivolumab and relatlimabrmbw) | New policy |
| Aug 2, 2026 | Point32Health | Opdualag (nivolumab and relatlimab-rmbw) | New policy |
| Aug 2, 2026 | Point32Health | Omisirge (omidubicel-onlv) | New policy |
| Aug 2, 2026 | Point32Health | Omisirge (omidubicel-onlv) | New policy |